Pharma stocks plunge as Trump’s 100% tariffs send shockwaves across Asia.
Hosted by Michelle Martin, we break down the impact on Singapore’s $4 billion pharma exports, Sumitomo Pharma, CSL, and more. Are these tariffs a short-term blow or a long-term reset for Asian healthcare investments?
Plus, we spotlight Mapletree’s three Singapore REITs - Logistics, Industrial, and Pan-Asia Commercial - amid expected rate cuts.
Which one offers the best dividend yield and growth potential?
Dividend Titan’s Willie Keng shares his strategy for navigating healthcare risks and REIT opportunities.

Money and Me: Who Really Wins When Money Is Printed?
24:05

Market View: Is there a real path to de-escalation for the Iran conflict? Will the US market meltdown? AI’s Debt-Fueled Data Center Boom
26:05

Influence: The founders steering a Singapore Food Icon - Tanjong Rhu Pau
22:43